# Relation between hydroxychloroquine dose and continuation rate in patients with systemic lupus erythematosus

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/relation-between-hydroxychloroquine-dose-and-continuation-rate-in-patients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Shuhei Takeyama,Michihito Kono,Kuniyuki Aso,Kazuro Kamada,Maria Tada,Masato Tarumi,Yui Kosumi,Masaru Yoshimura,Keita Ninagawa,Ryo Hisada,Yuichiro Fujieda,Masaru Kato,Olga Amengual,Tatsuya Atsumi |
| Citations | 4 |
| DOI | 10.1093/mr/roae062 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1093/mr/roae062 |
| OpenAlex ID | https://openalex.org/W4401729256 |
| PMID | 39163257 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Shuhei Takeyama](https://scholariq.org/researchers/shuhei-takeyama/)

## Paper journal

- [Modern Rheumatology](https://scholariq.org/journals/modern-rheumatology/)

## Paper primary topic

- [Drug-Induced Ocular Toxicity](https://scholariq.org/topics/drug-induced-ocular-toxicity/)

## Paper topics

- [Drug-Induced Ocular Toxicity](https://scholariq.org/topics/drug-induced-ocular-toxicity/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.